85 WELLS AVENUE, NEWTON, MA
Market cap: $56.3M (2/09/2026)
Price: $6.59
Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
Karyopharm Therapeutics Closes Financing Transactions with Lenders
Karyopharm Strategic Financing Extends Cash Runway to Q2 2026
Changes in Board, Management or Compensation
Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
Investor Presentation
News
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
SC TO-I
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer